Samit Hirawat, EVP, Chief Med.Offr, Drug Development at BRISTOL MYERS SQUIBB CO (BMY), bought 3,646 shares at $54.84 ($200K) on 2025-02-14, disclosed to the SEC on 2025-02-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.84 | 1,823 | $100K | 50.0% |
| 2 | $54.84 | 1,823 | $100K | 50.0% |
| Total | $54.85 avg | 3,646 | $200K | 100% |
| Filing → |